Molecular Neuropsychiatry Research Branch, DHHS/NIH/NIDA Intramural Research Program, Baltimore, MD 21224, USA.
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):526-38. doi: 10.2174/187152710793361496.
Dopamine (DA), the most abundant catecholamine in the basal ganglia, participates in the regulation of motor functions and of cognitive processes such as learning and memory. Abnormalities in dopaminergic systems are thought to be the bases for some neuropsychiatric disorders including addiction, Parkinson's disease, and Schizophrenia. DA exerts its arrays of functions via stimulation of D1-like (D1 and D5) and D2-like (D2, D3, and D4) DA receptors which are located in various regions of the brain. The DA D1 and D2 receptors are very abundant in the basal ganglia where they exert their functions within separate neuronal cell types. The present paper focuses on a review of the effects of stimulation of DA D1 receptors on diverse signal transduction pathways and gene expression patterns in the brain. We also discuss the possible involvement of the DA D1 receptors in DA-mediated toxic effects observed both in vitro and in vivo. Future studies using more selective agonist and antagonist agents and the use of genetically modified animals should help to further clarify the role of these receptors in the normal physiology and in pathological events that involve DA.
多巴胺(DA)是基底神经节中含量最丰富的儿茶酚胺,参与运动功能和认知过程(如学习和记忆)的调节。多巴胺能系统的异常被认为是一些神经精神疾病的基础,包括成瘾、帕金森病和精神分裂症。DA 通过刺激位于大脑不同区域的 D1 样(D1 和 D5)和 D2 样(D2、D3 和 D4)DA 受体发挥其多种功能。DA D1 和 D2 受体在基底神经节中非常丰富,在那里它们在不同的神经元细胞类型中发挥作用。本文重点讨论了刺激 DA D1 受体对大脑中不同信号转导途径和基因表达模式的影响。我们还讨论了 DA D1 受体在体外和体内观察到的 DA 介导的毒性作用中的可能参与。使用更选择性的激动剂和拮抗剂以及使用基因修饰动物的未来研究应有助于进一步阐明这些受体在正常生理和涉及 DA 的病理事件中的作用。